1428. Increased Consumption of Pivmecillinam in Primary Care for Uncomplicated Urinary Tract Infection (uUTI) Is Not Associated With Increased Resistance Rates

BACKGROUND: The evolution of antibiotic resistance in Escherichia coli (E. coli) hampers the treatment of UTIs, mirroring the global public health concerns around antimicrobial resistance. Pivmecillinam, an oral prodrug of mecillinam (a β-lactam antibiotic), is used as first-line treatment for uUTIs...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Anders Rhod, Henriksen, Anne Santerre, Frimodt-Møller, Niels
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644580/
http://dx.doi.org/10.1093/ofid/ofab466.1620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644580/
http://dx.doi.org/10.1093/ofid/ofab466.1620

Ejemplares similares